A pioneering new breast cancer research unit has been officially opened by HRH The Prince of Wales.
This facility marks a significant step forward for breast cancer research in Scotland.
The Breakthrough Breast Cancer Research Unit at the University of Edinburgh will be based at the Institute of Genetics and Molecular Medicine.
It will bring together some of the best scientists and doctors in Scotland to develop a centre of excellence for world-class breast cancer research.
The unit’s location adjacent to the Edinburgh Breast Clinic will help ensure laboratory results are turned into direct benefits for patients as quickly as possible.
Scientists at the unit will focus on improving treatment for hormone-sensitive breast cancer, the most common form of the disease.
Women with this type of tumour are usually treated with hormone therapies such as tamoxifen but not everyone benefits from these treatments.
Many women experience the problem of drug resistance where their treatment stops working.
The unit’s aim is to ensure women are treated in the most effective way for their particular type of breast cancer, overcoming or avoiding the problem of drug resistance.
By bringing together some of the best scientific and clinical minds in the country, we will be able to improve treatment available for women and ensure patients are able to reap the benefits of our work as quickly as possible.